Arana-Linares, A.C.; Caicedo, P.A.; Villegas-Torres, M.F.; González-Barrios, A.F.; Cortes, N.; Osorio, E.H.; Salamanca, C.H.; Barrera-Ocampo, A.
Preformulation Study of Controlled-Release Galantamine Matrix Tablets Containing Polyethylene Oxide, Hydroxypropyl Methylcellulose, and Ethylcellulose. Pharmaceutics 2025, 17, 1139.
https://doi.org/10.3390/pharmaceutics17091139
AMA Style
Arana-Linares AC, Caicedo PA, Villegas-Torres MF, González-Barrios AF, Cortes N, Osorio EH, Salamanca CH, Barrera-Ocampo A.
Preformulation Study of Controlled-Release Galantamine Matrix Tablets Containing Polyethylene Oxide, Hydroxypropyl Methylcellulose, and Ethylcellulose. Pharmaceutics. 2025; 17(9):1139.
https://doi.org/10.3390/pharmaceutics17091139
Chicago/Turabian Style
Arana-Linares, Andres C., Paola A. Caicedo, MarÃa Francisca Villegas-Torres, Andrés F. González-Barrios, Natalie Cortes, Edison H. Osorio, Constain H. Salamanca, and Alvaro Barrera-Ocampo.
2025. "Preformulation Study of Controlled-Release Galantamine Matrix Tablets Containing Polyethylene Oxide, Hydroxypropyl Methylcellulose, and Ethylcellulose" Pharmaceutics 17, no. 9: 1139.
https://doi.org/10.3390/pharmaceutics17091139
APA Style
Arana-Linares, A. C., Caicedo, P. A., Villegas-Torres, M. F., González-Barrios, A. F., Cortes, N., Osorio, E. H., Salamanca, C. H., & Barrera-Ocampo, A.
(2025). Preformulation Study of Controlled-Release Galantamine Matrix Tablets Containing Polyethylene Oxide, Hydroxypropyl Methylcellulose, and Ethylcellulose. Pharmaceutics, 17(9), 1139.
https://doi.org/10.3390/pharmaceutics17091139